ID

DB10581||

名称

Khuskia oryzae

描述

Khuskia oryzae is a fungus which can provoke allergic reactions. Khuskia oryzae extract is used in allergenic testing.

cas号

唯一标识码

VK8C112WTS

状态

组

approved,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

消除途径

种类

Cell-mediated Immunity

Increased Histamine Release

Increased IgG Production

Non-Standardized Fungal Allergenic Extract

盐类

蛋白质结合

清除

同义词

国际品牌

配送量

产品

name:B Mold Mixture
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0035
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-04-13
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:B Mold Mixture
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0037
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-23
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:B Mold Mixture
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0036
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-23
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Khuskia Oryzae
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-6540
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.10 g/1mL
route:Percutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0327
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-04-13
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0328
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-23
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2025
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2020
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2022
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2026
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2019
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2027
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2021
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2024
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora sphaerica
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2023
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:40000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Nigrospora Sphaerica
labeller:Allergy Laboratories, Inc.
ndc-id:
ndc-product-code:54575-212
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1967-12-07
ended-marketing-on:
dosage-form:Injection, solution
strength:1 g/20mL
route:Percutaneous; Subcutaneous
fda-application-number:BLA101376
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Rinkel Mold Mix B
labeller:Allergy Laboratories, Inc.
ndc-id:
ndc-product-code:54575-229
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1967-12-07
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Percutaneous; Subcutaneous
fda-application-number:BLA101376
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS128871
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0659
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC

混合物

name:B Mold Mixture
ingredients:Cochliobolus spicifer + Colletotrichum coccodes + Hypomyces perniciosus + Khuskia oryzae + Microascus brevicaulis + Myrothecium verrucaria + Neurospora crassa + Paecilomyces variotii + Passalora fulva + Pleospora herbarum + Streptomyces griseus + Trichoderma viride + Trichophyton schoenleinii + Trichothecium roseum
name:B Mold Mixture
ingredients:Cochliobolus spicifer + Colletotrichum coccodes + Hypomyces perniciosus + Khuskia oryzae + Microascus brevicaulis + Myrothecium verrucaria + Neurospora crassa + Paecilomyces variotii + Passalora fulva + Pleospora herbarum + Streptomyces griseus + Trichoderma viride + Trichophyton schoenleinii + Trichothecium roseum
name:B Mold Mixture
ingredients:Cochliobolus spicifer + Colletotrichum coccodes + Hypomyces perniciosus + Khuskia oryzae + Microascus brevicaulis + Myrothecium verrucaria + Neurospora crassa + Paecilomyces variotii + Passalora fulva + Pleospora herbarum + Streptomyces griseus + Trichoderma viride + Trichophyton schoenleinii + Trichothecium roseum
name:Nigrospora
ingredients:Khuskia oryzae
name:Nigrospora
ingredients:Khuskia oryzae
name:Treatment Set TS128871
ingredients:Acrothecium robustum + Apiospora montagnei + Canis lupus familiaris hair + Cladosporium cladosporioides + Cochliobolus spicifer + Colletotrichum coccodes + Felis catus hair + Humicola grisea + Hypomyces perniciosus + Khuskia oryzae + Microascus brevicaulis + Microsporum audouinii + Microsporum canis + Mycocladus corymbiferus + Myrothecium verrucaria + Neurospora crassa + Paecilomyces variotii + Passalora fulva + Phycomyces blakesleeanus + Pleospora herbarum + Sarocladium strictum + Sporisorium cruentum + Sporotrichum pruinosum + Stachybotrys chartarum + Streptomyces griseus + Syncephalastrum racemosum + Tetracoccosporium paxianum + Trichoderma viride + Trichophyton schoenleinii + Trichothecium roseum + Ustilago cynodontis + Verticillium albo-atrum
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora sphaerica
ingredients:Khuskia oryzae
name:Nigrospora Sphaerica
ingredients:Khuskia oryzae
name:Rinkel Mold Mix B
ingredients:Cochliobolus spicifer + Helminthosporium solani + Khuskia oryzae + Microascus brevicaulis + Mycogone nigra + Myrothecium verrucaria + Neurospora crassa + Paecilomyces variotii + Passalora fulva + Pleospora tarda + Streptomyces griseus + Trichoderma viride + Trichophyton schoenleinii + Trichothecium roseum
name:Khuskia Oryzae
ingredients:Khuskia oryzae

包装者

生产者

价格

受影响的生物体

剂量

form:Injection, solution
route:Intradermal; Subcutaneous
strength:
form:Injection, solution
route:Percutaneous
strength:0.10 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.05 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.1 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:10000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:20000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:40000 [PNU]/1mL
form:Injection, solution
route:Percutaneous; Subcutaneous
strength:1 g/20mL
form:Injection, solution
route:Percutaneous; Subcutaneous
strength:

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

序列

实验性质

外部标识符

resource：PubChem Substance
identifier：347910740
resource：Wikipedia
identifier：Khuskia_oryzae
resource：RxCUI
identifier：892338

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应